118 related articles for article (PubMed ID: 30473499)
1. Development and validation of HPLC method for the determination of Candesartan in human plasma.
Hamid S; Beg AE; Muhammad IN; Hassan S; Hassan A; Akram A; Alladin N
Pak J Pharm Sci; 2018 Nov; 31(6):2323-2327. PubMed ID: 30473499
[TBL] [Abstract][Full Text] [Related]
2. HPLC method development and validation for the determination of Cefaclor in human plasma.
Naz S; Shoaib MH; Bashir L; Yousuf RI; Anjum F; Siddiqui F; Yaseen S
Pak J Pharm Sci; 2017 Sep; 30(5):1645-1649. PubMed ID: 29084685
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of HPLC method for the determination of Cefpodoxime Proxetil in human plasma.
Bashir L; Shoaib MH; Naz S; Yousuf RI; Jabeen S; Israr F; Siddiqui F
Pak J Pharm Sci; 2017 Sep; 30(5):1603-1607. PubMed ID: 29084679
[TBL] [Abstract][Full Text] [Related]
4. Simple RP-HPLC method for determination of triple drug combination of valsartan, amlodipine and hydrochlorothiazide in human plasma.
Sharma RN; Pancholi SS
Acta Pharm; 2012 Mar; 62(1):45-58. PubMed ID: 22472448
[TBL] [Abstract][Full Text] [Related]
5. Chromatographic method development and validation for the determination of valsartan in biological fluid.
Ghayas S; Shoaib MH; Siddiqui F; Yousuf RI; Masood MA; Anjum F; Bushra R; Bashir L; Naz S; Muhammad IN
Pak J Pharm Sci; 2017 Nov; 30(6(Supplementary)):2355-2362. PubMed ID: 29188769
[TBL] [Abstract][Full Text] [Related]
6. Determination and validation of ketoprofen, pantoprazole and valsartan together in human plasma by high performance liquid chromatography.
Koçyiğit-Kaymakçoğlu B; Unsalan S; Rollas S
Pharmazie; 2006 Jul; 61(7):586-9. PubMed ID: 16889064
[TBL] [Abstract][Full Text] [Related]
7. Optimization via experimental design of an SPE-HPLC-UV-fluorescence method for the determination of valsartan and its metabolite in human plasma samples.
Iriarte G; Ferreirós N; Ibarrondo I; Alonso RM; Maguregi MI; Gonzalez L; Jiménez RM
J Sep Sci; 2006 Oct; 29(15):2265-83. PubMed ID: 17120810
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of reverse phase HPLC method for determination of angiotensin receptor blocking agent irbesartan in plasma.
Nisa Z; Ali SI; Rizvi M; Khan MA; Sultan RA; Fatima R; Shaheen N; Zafar F; Kashif SS; Khatian N
Pak J Pharm Sci; 2019 Mar; 32(2 (Supplementary)):853-858. PubMed ID: 31103982
[TBL] [Abstract][Full Text] [Related]
9. Quantitative bio-analysis of pitavastatin and candesartan in rat plasma by HPLC-UV: Assessment of pharmacokinetic drug-drug interaction.
Patel M; Kothari C
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Feb; 1138():121962. PubMed ID: 31915110
[TBL] [Abstract][Full Text] [Related]
10. A simple, rapid and fully validated HPLC method for simultaneous quantitative bio-analysis of rosuvastatin and candesartan in rat plasma: Application to pharmacokinetic interaction study.
Patel M; Kothari C
Biomed Chromatogr; 2019 Oct; 33(10):e4607. PubMed ID: 31141832
[TBL] [Abstract][Full Text] [Related]
11. Determination of azide impurity in sartans using reversed-phase HPLC with UV detection.
Gričar M; Andrenšek S
J Pharm Biomed Anal; 2016 Jun; 125():27-32. PubMed ID: 26999319
[TBL] [Abstract][Full Text] [Related]
12. Determination of candesartan cilexetil, candesartan and a metabolite in human plasma and urine by liquid chromatography and fluorometric detection.
Stenhoff H; Lagerström PO; Andersen C
J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(2):411-7. PubMed ID: 10510797
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of gender difference in pharmacokinetics of Candesartan cilexetil in the fasted state by RP-HPLC: A single dose comparative study.
Nawaz HA; Masood MI; Abbas M; Usman M; Khan AM; Rasheed H; Riffat S
Pak J Pharm Sci; 2019 May; 32(3):1019-1024. PubMed ID: 31278715
[TBL] [Abstract][Full Text] [Related]
14. Simple and effective HPLC method development and its validation for Clindipine in human drug free plasma.
Muralidharan S; Kumar Jr; Dhanaraj SA
Pak J Pharm Sci; 2015 Jan; 28(1):135-8. PubMed ID: 25553676
[TBL] [Abstract][Full Text] [Related]
15. Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection.
González L; López JA; Alonso RM; Jiménez RM
J Chromatogr A; 2002 Mar; 949(1-2):49-60. PubMed ID: 11999756
[TBL] [Abstract][Full Text] [Related]
16. DEVELOPMENT AND VALIDATION OF HPLC ANALYTICAL METHODS USED-FOR DETERMINATION OF ASSAY, CONTENT UNIFORMITY AND DISSOLUTION OF IMMEDIATE RELEASE CANDESARTAN CILEXETIL 32 MG TABLETS.
Yuce M; Capan Y
Acta Pol Pharm; 2017 Mar; 74(2):357-367. PubMed ID: 29624240
[TBL] [Abstract][Full Text] [Related]
17. HPLC determination of irbesartan in human plasma: its application to pharmacokinetic studies.
Bae SK; Kim MJ; Shim EJ; Cho DY; Shon JH; Liu KH; Kim EY; Shin JG
Biomed Chromatogr; 2009 Jun; 23(6):568-72. PubMed ID: 19277953
[TBL] [Abstract][Full Text] [Related]
18. Rapid determination of valsartan in human plasma by protein precipitation and high-performance liquid chromatography.
Macek J; Klíma J; Ptácek P
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 832(1):169-72. PubMed ID: 16426905
[TBL] [Abstract][Full Text] [Related]
19. Improved analytical validation and pharmacokinetics of valsartan using HPLC with UV detection.
Piao ZZ; Lee ES; Tran HT; Lee BJ
Arch Pharm Res; 2008 Aug; 31(8):1055-9. PubMed ID: 18787797
[TBL] [Abstract][Full Text] [Related]
20. High-performance liquid chromatographic analysis of angiotensin II receptor antagonist valsartan using a liquid extraction method.
Daneshtalab N; Lewanczuk RZ; Jamali F
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(2):345-9. PubMed ID: 11824822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
